Sunday, May 8, 2011

Amanda Peet 2012 movie and vaccinations

http://en.wikipedia.org/wiki/Stephen_Friedman_xcerpt:Friedman's
Excerpt:
son is screenwriter David Benioff, who is married to actress Amanda Peet.[citation needed]

Stephen Friedman (born December 21, 1937)[1] is the former Chairman of the United States President's Foreign Intelligence Advisory Board. He was nominated on October 27, 2005 to replace Brent Scowcroft in the position.


[edit] Life and career

Friedman graduated from Cornell University in 1959, where he was a wrestler and a member of the Quill and Dagger society. He received his law degree from Columbia Law School in 1962 (Law Review). He worked for much of his career with investment bank Goldman Sachs, holding numerous executive roles. He served as the company's co-chief operating officer from 1987 to 1990, was the company's co-chairman from 1990 to 1992, and the sole chairman from 1992 to 1994; he still serves on the company board.
From 1998 to 2002, he served as a senior principal of Marsh & McLennan Capital Corp. He was from 2002 to 2005 United States Assistant to the President for Economic Policy and director of the National Economic Council.
Among other public service activities, Friedman is the Chairman Emeritus of the Board of Columbia University, Chairman Emeritus of the Executive Committee of the Brookings Institution, and a member of the Council on Foreign Relations. He is also a benefactor of his alma mater Cornell University, particularly its wrestling program as the college's wrestling building is known as the Friedman Center.
On May 7, 2009 Friedman resigned as Chairman of the Federal Reserve Bank of New York in response to criticism of his December 2008 purchase of $3 million of stock in Goldman Sachs.[2] Friedman, who remains a member of Goldman Sachs' board, came into violation of Federal Reserve policy when Goldman was converted to a bank holding company in September 2008, thereby placing it under the regulatory authority of the New York Fed. Friedman requested a waiver from this violation when the conversion occurred, which was granted roughly two and a half months later.[3] In his resignation letter, Friedman stated that the Fed did not need the "distraction" caused by his "public service motivated continuation on the Reserve Bank Board...being characterized as improper."

[edit] Personal life

Friedman's brother is Richard Friedman, a law professor at the University of Michigan and a leading expert in the Confrontation Clause of the United States Constitution.[citation needed]
Friedman's son is screenwriter David Benioff, who is married to actress Amanda Peet.[citation needed]

http://www.sourcewatch.org/index.php?title=Brent_Scowcroft
Excerpt:


http://articles.nydailynews.com/2008-09-30/gossip/29435141_1_childhood-vaccines-autism-treatment-jenny-mccarthy
Excerpt:
Jenny McCarthy and Amanda Peet duke it out over childhood vaccines and autism
BY ROSEMARY BLACK
DAILY NEWS STAFF WRITER
Tuesday, September 30, 2008
Both Jenny McCarthy and Amanda Peet have impressive credits attached to their names, but M.D. isn't one of them.
But that hasn't stopped them from raging a war in the press over childhood vaccines.
McCarthy, whose son is autistic, is against childhood vaccines because she believes there is a correlation between the shots and the impairment.
Peet, who has a toddler as well, is the spokesperson for Every Child By Two, a non-profit group that wants all kids vaccinated by age two. She labeled such anti-vaccine parents as "parasites" in a recent interview with Cookie.

Autism Masters Degree
Earn a Degree in Behavioral Intervention & Autism 100% Online! http://www.umassonline.net/
The article reignited sparks in what's been a lengthy debate over whether or not vaccines are in fact linked to autism.
Responding in Spectrum magazine, McCarthy says, "I am so proud to be a 'parasite.'"
Even though Peet later apologized for using the word "parasite," that has not quieted her critics.
"She did not apologize for what she said, she just apologized for the term 'parasite,'" says Amy Pisani, executive director of Every Child By Two. "We aren't here to talk about Jenny McCarthy or to argue about Jenny McCarthy. Amanda is just trying to give people access to the scientific information so they can make an informed decision about vaccinating a child, just as she did."
Autism, which is characterized by impairments in social communication and interaction, affects about 1 in 150 children and is typically diagnosed between the ages of 18 and 36 months. It affects four times as many boys as girls. Though early intervention is very effective, there so far is no proven cause of the disorder. Genetics is believed to play a role.
The American Academy recently released the following statement: "There is no valid scientific evidence that vaccines cause autism. But because of unfounded fears about vaccines, the U.S. is suffering its biggest measles outbreak in a decade."
More than 130 cases of measles have been diagnosed in the U.S. since the beginning of the year, says Dr. Ivy Chong, program director at the Scott Center for Autism Treatment at the Florida Institute of Technology. "Of these cases, 91 percent of the individuals who got measles had not been vaccinated," Chong says.
Why do parents believe there is a link between autism and vaccines?
Dr. Martin Myers, professor of both Pediatrics and Preventive Medicine & Community Health at the University of Texas Medical Branch and author of "Do Vaccines Cause This?" says it could be because autism shows up right around when shots are being given.
"We give a lot of vaccines to kids and we give them when the kids are young, often at the same time that developmental problems an be detected," he says. "It's hard for a parent to understand that the association is just coincidental."
Childhood vaccines have become suspect in recent years - especially as the number of recommended shots has grown. In 1983, the CDC recommended 23 doses of seven vaccines for kids up to age six. Today that number has climbed to 48 doses of 12 vaccines - and that doesn't even count the flu shot.


http://www.ageofautism.com/2008/08/every-child-by.html
Excerpt:
On the firing line was Lederle Laboratories of Wayne, NJ, one of the largest manufacturers of DTP vaccine at the time. A spokesperson for Lederle was charged with working the press to try and defend DTP, mercury, and vaccines in general--he was the Paul Offit of his time. This spokesperson, in January 1991, was quoted in the New York Times saying, "Any chemical product, because it is a chemical substance, does produce some side effects. The current vaccine [DTP], as far as we are concerned, is a very safe and efficacious vaccine."

http://en.wikipedia.org/wiki/Wyeth
Excerpt:
Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), was a pharmaceutical company. The company was based in Madison, New Jersey, USA. They were known for manufacturing the over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen), as well as the prescription drugs Premarin and Effexor, which both boast over US$3 billion in sales annually.
On January 23, 2009 The Wall Street Journal reported that Pfizer was in talks to buy Wyeth at a cost of US$68 billion.[1] On January 25, Pfizer agreed to the purchase, a deal financed with cash, shares and loans.[2] The deal was completed on October 15, 2009.[3]

http://www.carlyle.com/Media%20Room/News%20Archive/2010/item10919.html
Excerpt:
Mr. Essner said, "I am excited to join Carlyle and partner with the Carlyle healthcare team. We see a range of opportunities in the U.S. and globally for private capital to help strengthen and improve the efficiency and effectiveness of the healthcare sector."

Mr. Essner served at Wyeth from 1989-2008, where he led Wyeth's transformation into a global leader in biotechnology and vaccines. After joining Wyeth (formerly American Home Products Corporation) in 1989 as Senior Vice President, Sales and Marketing, for Wyeth-Ayerst Laboratories, Mr. Essner was named Executive Vice President for Wyeth-Ayerst Laboratories in 1991. He then became President of Wyeth-Ayerst Laboratories in 1993. In 1997, Mr. Essner was named President of Wyeth-Ayerst Global Pharmaceuticals and was elected to the position of Executive Vice President and member of the Board of Directors for Wyeth. In 2000, he was named President and Chief Operating Officer. In 2001, Mr. Essner was elected Chief Executive Officer and in 2003 he became Chairman; he retired from both positions in 2008. Mr. Essner joined Wyeth from Sandoz Pharmaceuticals Corporation where he was Chief Operating Officer.

http://www.us.sandoz.com/site/en/company/profile/history/content.shtml
Excerpt:
1996 By December, Ciba-Geigy, Ltd. and Sandoz Ltd. merged to form Novartis AG. With this merger, Novartis AG became one of the largest pharmaceutical companies in the world. 

http://www.fundinguniverse.com/company-histories/CibaGeigy-Ltd-Company-History.html
Excerpt:
Early in the century both Ciba and Geigy established factories in Germany, due in part to a labor shortage in Switzerland, but also to avoid enforcement of environmental laws designed to reduce pollution in the River Rhine.

http://en.wikipedia.org/wiki/Ciba_Specialty_Chemicals
Excerpt:
History
Part of the merger agreement between Ciba Geigy and Sandoz was that the former's industrial chemicals business would be spun off as a separate business, leading to the formation of Ciba Specialty Chemicals plc.
In 2004 Ciba bought paper chemical manufacturer Raisio Chemicals from Raisio Group. In 2006, Ciba divested its Textile Dyes and Chemical Auxiliaries business in a sale to Huntsman Corporation.
In 2007 the company announced the intention to adopt the name Ciba Inc.
Ciba's board of directors agreed to a €3.4 billion takeover offer from BASF, the world's largest chemicals company, on 15 September 2008.[5]

[edit] Board of directors

  • Michael Heinz Chief Executive Officer
  • Armin Meyer Chairman of the Board
  • Beat W. Hess Vice Chairman of the Board
  • Utz-Hellmuth Felcht Member of the Board
  • Erwin W. Heri Member of the Board
  • Gertrud Höhler Member of the Board
  • Jean-Marie Pierre Lehn Member of the Board
  • Peter Littmann Member of the Board
  • Uli Sigg Member of the Board
http://www.basf.com/group/corporate/en/about-basf/corporate-management/board/heinz


http://www.corporateaccountability2010.com/london/faculty/beat-hess.php
Excerpt:
1972 - 1975
Various positions as legal advisor to Swiss government agencies and as law clerk at Swiss courts.

1977 - 1987

Legal counsel BBC Brown Boveri Ltd, a multinational engineering group and manufacturer of power plants and electrical equipment, domiciled in Switzerland.
International and multilingual practice with a wide range of transactional legal matters, contracts for large projects and extensive negotiation and drafting experience.

1988 to 2003

General Counsel ABB Group, created in 1988 after the merger between the BBC Brown Boveri and ASEA groups, with business activities in over 150 countries, mainly in power and automation technologies, oil, gas and petrochemical equipment, industrial installations and financial services; approx. 160,000 employees and USD 26 billion in sales.
Broad experience in leading a legal and compliance department with 150 lawyers, 50 compliance officers and over 50 intellectual property specialists; advice to Group Executive Management and Board of Directors on all legal matters of group-wide importance; leadership or key role in negotiations of large acquisitions, divestments, joint ventures and other transactions; ultimate responsibility for all major legal issues, including litigation, intellectual property matters, risk assessments in large projects, group sales and agency organization, intra-group funding schemes and arms' length dealing terms, corporate organization; ultimate responsibility for compliance and risk management matters.

2003 to present

Group Legal Director and Member of the Group Executive Committee of Royal Dutch Shell plc.
Head of a global legal function with some 650 lawyers and approx. 350 intellectual property professionals, compliance officers, paralegals and support staff worldwide.
Member of the Shell Group Executive Committee with wide responsibilities for all legal, intellectual property (patents, trademarks) and compliance matters; ultimate accountability for all major litigation, corporate transactions and proceedings, regulatory affairs, the governance and structure of the Royal Dutch Shell Group, and for all legal aspects of the Group's business activities, strategic orientation and relationship with its stakeholders.

Dec 31, 2010 ... Dr. Beat W. Hess. Legal Director, Member of the Group. Executive Committee, Royal Dutch Shell plc, The Hague. Prof. Dr. Arnold Koller. Former member of the Swiss Federal ..... BASF, Ludwigshafen. Dr. Hanno Wollmann ...
www.mbl.unisg.ch/de/content/download/396/1865/version/8... www.mbl.unisg.ch/de/content/download/396/1865/version/8/file/Definitiv_MBL_Studienbroschuere_2010.pdf

http://www.answers.com/topic/schindler-holding-ag
Excerpt:
In 1985 a new generation of management took over the Schindler group. Alfred N. Schindler--an MBA graduate of the renowned Wharton School of Finance in Pennsylvania, as well as a graduate of the University of Bern Law School--together with Luc Bonnard and Dr. Uli Sigg were elected at the general shareholder meeting as the new executive directors.

http://en.wikipedia.org/wiki/Jean-Marie_Lehn
Excerpt:

Jean-Marie Lehn

Born30 September 1939 (1939-09-30) (age 71)
Rosheim, France
NationalityFrance
FieldsSupramolecular chemistry
Known forcryptands
Notable awardsNobel prize in Chemistry in 1987

Jean-Marie Lehn (born September 30, 1939) is a French chemist. He received the Nobel Prize together with Donald Cram and Charles Pedersen in 1987 for his work in Chemistry, particularly his synthesis of the cryptands. Lehn was an early innovator in the field of supramolecular chemistry, i.e., the chemistry of host-guest molecular assemblies created by intermolecular interactions, and continues to innovate in this field. He has published in excess of 800 peer-reviewed articles in chemistry literature.

http://vactruth.com/2009/09/21/study-clearly-demonstrates-that-aluminum-found-in-vaccines-can-cause-neurologic-damage/
Excerpt:

Study clearly demonstrates that aluminum found in vaccines can cause neurologic damage

By Admin - vactruth.com | September 21st, 2009 | Category: Top Stories | 0 Comments and 0 Reactions

Article can be found here. Roman puts out well-researched information. If you want to stay abreast of current health issues, sign up for the Health Sentinel Newsletter.
Written by Roman Bystrianyk
Monday, 21 September 2009 22:17
injection
Randi Allaire was an Information Management Specialist in the military for almost four years. Three and one-half years were spent with the Air National Guard as Information Management, the previous five and half was with the Army Guard as a Flight Operations Specialist.
As part of the military’s program to protect their troops from chemical and biological weapons, Randi was required to take the anthrax vaccine. On March 14, 1999 she was given her fourth anthrax vaccine. It was after that shot that she has suffered chronic fatigue, memory lapses, migraines, pain in the forearms, and other aches and pains. She received no help with her condition and only denials that the anthrax vaccine could cause any of these problems and that the cause of her problems was likely the “flu” or too much “stress”. She was eventually thrown out of the military because she refused to take the fifth anthrax vaccine shot in fear for her own personal health.

http://www.ncbi.nlm.nih.gov/pubmed/17114826
Excerpt:
Neuromolecular Med. 2007;9(1):83-100.

Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.

Petrik MS, Wong MC, Tabata RC, Garry RF, Shaw CA.

Source

Department of Ophthalmology and Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada. mspetrik@interchange.ubc.ca

Abstract

Gulf War illness (GWI) affects a significant percentage of veterans of the 1991 conflict, but its origin remains unknown. Associated with some cases of GWI are increased incidences of amyotrophic lateral sclerosis and other neurological disorders. Whereas many environmental factors have been linked to GWI, the role of the anthrax vaccine has come under increasing scrutiny. Among the vaccine's potentially toxic components are the adjuvants aluminum hydroxide and squalene. To examine whether these compounds might contribute to neuronal deficits associated with GWI, an animal model for examining the potential neurological impact of aluminum hydroxide, squalene, or aluminum hydroxide combined with squalene was developed. Young, male colony CD-1 mice were injected with the adjuvants at doses equivalent to those given to US military service personnel. All mice were subjected to a battery of motor and cognitive-behavioral tests over a 6-mo period postinjections. Following sacrifice, central nervous system tissues were examined using immunohistochemistry for evidence of inflammation and cell death. Behavioral testing showed motor deficits in the aluminum treatment group that expressed as a progressive decrease in strength measured by the wire-mesh hang test (final deficit at 24 wk; about 50%). Significant cognitive deficits in water-maze learning were observed in the combined aluminum and squalene group (4.3 errors per trial) compared with the controls (0.2 errors per trial) after 20 wk. Apoptotic neurons were identified in aluminum-injected animals that showed significantly increased activated caspase-3 labeling in lumbar spinal cord (255%) and primary motor cortex (192%) compared with the controls. Aluminum-treated groups also showed significant motor neuron loss (35%) and increased numbers of astrocytes (350%) in the lumbar spinal cord. The findings suggest a possible role for the aluminum adjuvant in some neurological features associated with GWI and possibly an additional role for the combination of adjuvants.

Alan Shaw on the Benefits of Industrial Biotechnology
http://www.youtube.com/watch?v=e5u3qPj8MNg

http://en.wikipedia.org/wiki/DNA_shuffling
Excerpt:
DNA shuffling is a way to rapidly propagate beneficial mutations in a directed evolution experiment. It is used to rapidly increase DNA library size. [1]

Contents

[hide]

[edit] Procedure

DNAse I is first used to fragment a set of parent genes into pieces of 50-100 bp in length. This is then followed by a polymerase chain reaction (PCR) without primers- DNA fragments with sufficient overlapping homologous sequence will anneal to each other and are then extended by DNA polymerase.
Several rounds of this PCR extension are allowed to occur, after some of the DNA molecules reach the size of the parental genes. These genes can then be amplified with another PCR, this time with the addition of primers that are designed to complement the ends of the strands. The primers may have additional sequences added to their 5' ends, such as sequences for restriction enzyme recognition sites needed for ligation into a cloning vector.
It is possible to recombine portion of these genes to generate hybrids or chimeric forms with unique properties, this is called DNA shuffling.

http://www.ncbi.nlm.nih.gov/pubmed/15011779
Excerpt:
Curr Opin Mol Ther. 2004 Feb;6(1):34-9.

Development of novel vaccines using DNA shuffling and screening strategies.

Locher CP, Soong NW, Whalen RG, Punnonen J.

Source

Maxygen Inc, Division of Infectious Diseases, 200 Penobscot Drive, Redwood City, CA 94063, USA. christopher.locher@maxygen.com

Abstract

DNA shuffling and screening technologies recombine and evolve genes in vitro to rapidly obtain molecules with improved biological activity and fitness. In this way, genes from related strains are bred like plants or livestock and their successive progeny are selected. These technologies have also been called molecular breeding-directed molecular evolution. Recent developments in bioinformatics-assisted computer programs have facilitated the design, synthesis and analysis of DNA shuffled libraries of chimeric molecules. New applications in vaccine development are among the key features of DNA shuffling and screening technologies because genes from several strains or antigenic variants of pathogens can be recombined to create novel molecules capable of inducing immune responses that protect against infections by multiple strains of pathogens. In addition, molecules such as co-stimulatory molecules and cytokines have been evolved to have improved T-cell proliferation and cytokine production compared with the wild-type human molecules. These molecules can be used to immunomodulate vaccine responsiveness and have multiple applications in infectious diseases, cancer, allergy and autoimmunity. Moreover, DNA shuffling and screening technologies can facilitate process development of vaccine manufacturing through increased expression of recombinant polypeptides and viruses. Therefore, DNA shuffling and screening technologies can overcome some of the challenges that vaccine development currently faces.

http://www.cov.com/practice/intellectual_property/patent_litigation/biotechnology/
Excerpt:
Representation of Maxygen in a case involving “gene shuffling.”  An arbitrator issued an injunction against opponent Enchira Biotechnology through 2017.  Maxygen was declared to be the exclusive owner of the technology as against Enchira, and was awarded attorneys fees and costs.


http://www.technologyreview.com/biomedicine/21362/?mod=related
Excerpt:
They found that 25 patients in a screen of more than 5,000 people with mental retardation, autism, or congenital abnormalities were missing a similar 1.35 megabase piece of DNA. No one within a similar size group of healthy people harbored a variation in that region, meaning that the deletion is the likely cause--at least in part--of the patients' problems.

Newsmaker: Brent Scowcroft on strategy in Afghanistan
http://www.youtube.com/watch?v=UtNlmNb3Ldk


http://en.wikipedia.org/wiki/Brent_Scowcroft
Excerpt:
Positions held
Prior to joining the Bush administration, Scowcroft was Vice Chairman of Kissinger Associates, Inc. He has had a long association with Henry Kissinger, having served as his assistant when Kissinger was the National Security Adviser under Nixon, from 1968.

Deputy Assistant For National Security Affairs Brent Scowcroft discusses the situation in Vietnam with Vice President Nelson A. Rockefeller and Central Intelligence Agency Director William Colby during a break in a meeting of the National Security Council., 04/24/1975
He is the founder and president of The Forum for International Policy, a think tank. Scowcroft is also president of The Scowcroft Group, Inc., an international business consulting firm. He is co-chair, along with Joseph Nye, of the Aspen Strategy Group. He is a member of the Trilateral Commission, Council on Foreign Relations, a board member of The Center for Strategic and International Studies and The Atlantic Council of the United States.[1]

http://en.wikipedia.org/wiki/List_of_Quill_and_Dagger_members
Excerpt:
Business

[edit] Banking and finance

[edit] Consumer products

http://www.ivygateblog.com/2010/03/secret-societies-stop-worshipping-satan-to-sell-t-shirts-become-total-pussies/
Excerpt:
Secret Societies Stop Worshipping Satan to Sell T-Shirts, Become Total Pussies
by Peter Finocchiaro | March 30, 2010 at 2:15 pm
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)